GS

Gouse Shaik

Active Director Director DIN 08835574
DIN 08835574 First appointment Aug 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Gouse Shaik

Data last updated:

Gouse Shaik is a Director at Gk1 Ayurvedam Private Limited (since 2020). The company operates in Healthcare. Gk1 Ayurvedam Private Limited reported revenue of ₹1.4 Lakh (FY 2022).

DIN 08835574
Primary Designation Director
Industry Healthcare
First Appointment 23 Aug 2020
Oldest Company Age 6 yrs
Largest company Gk1 Ayurvedam Private Limited · ₹1.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gk1 Ayurvedam Private Limited U85100AP2020PTC115458
Director23 Aug 20202020₹1.4 Lakh (FY 2022)Active

Board colleagues of Gouse Shaik

NameDINCompanyDesignation
Lenin Babu Konduru08835558Gk1 Ayurvedam Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gk1 Ayurvedam Private Limited
Premium access

Shareholding and investment profile for Gouse Shaik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gouse Shaik

Gouse Shaik currently holds 1 directorship: Gk1 Ayurvedam Private Limited (Director, since 23 Aug 2020, revenue ₹1.4 Lakh (FY 2022)).

Gouse Shaik was first appointed on 23 Aug 2020 as Director at Gk1 Ayurvedam Private Limited.

The current boards of Gouse Shaik's companies include Lenin Babu Konduru (Gk1 Ayurvedam Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available